Protective effects of marrubiin improve endometriosis through suppression of the expression of RANTES

Sun,Xiao‑Hong

doi:10.3892/mmr.2017.6969

Protective effects of marrubiin improve endometriosis through suppression of the expression of RANTES

Authors:
- Xiao‑Hong Sun
View Affiliations

Affiliations: Department of Gynecology, Nanhua Hospital Affiliated to Nanhua University, Hengyang, Hunan 421001, P.R. China
Published online on: July 14, 2017 https://doi.org/10.3892/mmr.2017.6969
Pages: 3339-3344

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Marrubiin can improve blood and lymph microcirculation disturbance, and has pharmacological effects in myocardial protection, anti‑inflammation and anti‑oxidation. The aim of the present study was to evaluate the protective effects of marrubiin on endometriosis through suppression of the expression of regulated on activation, normal T cell expressed and secreted (RANTES). Endometriotic cells were implanted into the peritoneal cavity of mice, and these mice were injected estradiol benzoate (30 µg/kg) once each day for 14 days. The mice with endometriosis were then treated with 12, 25 or 50 mg/kg marrubiin. Reverse transcription‑quantitative polymerase chain reaction was used to assess the mRNA expression of RANTES, and western blot analysis was used to analyze the protein expression of RANTES, TNF‑α and PGE2. Inflammation factors were measured by ELISA. Treatment with marrubiin effectively improved lesion regression and inhibited toxicity in the mouse model of endometriosis. Marrubiin significantly inhibited endometrial lesions and monocyte chemotaxis in the mice with endometriosis, and reduced U937 cell migration. Calcium mobilization, levels of tumor necrosis factor‑α and the secretion of RANTES were effectively suppressed by marrubiin treatment. The calcium levels were effectively induced, whereas the protein expression of prostaglandin E2 (PGE2) and formation of thromboxane B2 (TXB2) were effectively inhibited by marrubiin treatment. These findings indicated that the protective effect of marrubiin improved endometriosis in the mice through the suppression of inflammation and downregulation of the expression of RANTES, followed by mediation of the levels of calcium, PGE2 and TXB2.

View Figures

View References

1	Singh AK, Chattopadhyay R, Chakravarty B and Chaudhury K: Markers of oxidative stress in follicular fluid of women with endometriosis and tubal infertility undergoing IVF. Reprod Toxicol. 42:116–124. 2013. View Article : Google Scholar : PubMed/NCBI
2	Yun BH, Jeon YE, Chon SJ, Park JH, Seo SK, Cho S, Choi YS, Lee JS and Lee BS: The Prognostic Value of Individual Adhesion Scores from the Revised American Fertility Society Classification System for Recurrent Endometriosis. Yonsei Med J. 56:1079–1086. 2015. View Article : Google Scholar : PubMed/NCBI
3	Kondi-Pafiti A, Papakonstantinou E, Iavazzo C, Grigoriadis C, Salakos N and Gregoriou O: Clinicopathological characteristics of ovarian carcinomas associated with endometriosis. Arch Gynecol Obstet. 285:479–483. 2012. View Article : Google Scholar : PubMed/NCBI
4	Wang KC, Chang WH, Lee WL, Huang N, Huang HY, Yen MS, Guo CY and Wang PH: An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis. BMC Cancer. 14:8312014. View Article : Google Scholar : PubMed/NCBI
5	Sakr S, Naqvi H, Komm B and Taylor HS: Endometriosis impairs bone marrow-derived stem cell recruitment to the uterus whereas bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment. Endocrinology. 155:1489–1497. 2014. View Article : Google Scholar : PubMed/NCBI
6	Johnston JL, Reid H and Hunter D: Diagnosing endometriosis in primary care: Clinical update. Br J Gen Pract. 65:101–102. 2015. View Article : Google Scholar : PubMed/NCBI
7	Wang XQ, Yu J, Luo XZ, Shi YL, Wang Y, Wang L and Li DJ: The high level of RANTES in the ectopic milieu recruits macrophages and induces their tolerance in progression of endometriosis. J Mol Endocrinol. 45:291–299. 2010. View Article : Google Scholar : PubMed/NCBI
8	Yang Y, Zhang X, Zhou C, Huang X, Lin J and Xu H: Elevated immunoreactivity of RANTES and CCR1 correlate with the severity of stages and dysmenorrhea in women with deep infiltrating endometriosis. Acta Histochem. 115:434–439. 2013. View Article : Google Scholar : PubMed/NCBI
9	Hornung D, Ryan IP, Chao VA, Vigne JL, Schriock ED and Taylor RN: Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells. J Clin Endocrinol Metab. 82:1621–1628. 1997. View Article : Google Scholar : PubMed/NCBI
10	Mnonopi N, Levendal RA, Mzilikazi N and Frost CL: Marrubiin, a constituent of Leonotis leonurus, alleviates diabetic symptoms. Phytomedicine. 19:488–493. 2012. View Article : Google Scholar : PubMed/NCBI
11	Stulzer HK, Tagliari MP, Zampirolo JA, Cechinel-Filho V and Schlemper V: Antioedematogenic effect of marrubiin obtained from Marrubium vulgare. J Ethnopharmacol. 108:379–384. 2006. View Article : Google Scholar : PubMed/NCBI
12	De Jesus RA, Cechinel-Filho V, Oliveira AE and Schlemper V: Analysis of the antinociceptive properties of marrubiin isolated from Marrubium vulgare. Phytomedicine. 7:111–115. 2000. View Article : Google Scholar : PubMed/NCBI
13	Knöss W, Reuter B and Zapp J: Biosynthesis of the labdane diterpene marrubiin in Marrubium vulgare via a non-mevalonate pathway. Biochem J. 326:449–454. 1997. View Article : Google Scholar : PubMed/NCBI
14	Vercellini P, Consonni D, Barbara G, Buggio L, Frattaruolo MP and Somigliana E: Adenomyosis and reproductive performance after surgery for rectovaginal and colorectal endometriosis: A systematic review and meta-analysis. Reprod Biomed Online. 28:704–713. 2014. View Article : Google Scholar : PubMed/NCBI
15	Palm F, Walter I, Budik S, Kolodziejek J, Nowotny N and Aurich C: Influence of different semen extenders and seminal plasma on PMN migration and on expression of IL-1beta, IL-6, TNF-alpha and COX-2 mRNA in the equine endometrium. Theriogenology. 70:843–851. 2008. View Article : Google Scholar : PubMed/NCBI
16	Wessels JM, Linton NF, Croy BA and Tayade C: A review of molecular contrasts between arresting and viable porcine attachment sites. Am J Reprod Immunol. 58:470–480. 2007. View Article : Google Scholar : PubMed/NCBI
17	Ghosh D and Sengupta J: Delineating the prime mover action of progesterone for endometrial receptivity in primates. Indian J Med Res. 140:(Suppl). S130–S136. 2014.PubMed/NCBI
18	Abutorabi R, Baradaran A, Mostafavi F Sadat, Zarrin Y and Mardanian F: Evaluation of Tumor Necrosis Factor Alpha Polymorphism Frequencies in Endometriosis. Int J Fertil Steril. 9:329–337. 2015.PubMed/NCBI
19	Ozbilgin K, Turan A, Kahraman B, Atay C, Vatansever S, Uluer ET and Ozçakir T: Distribution of furin, TNF-α and TGF-β2 in the endometrium of missed abortion and voluntary first trimester termination cases. Anal Quant Cytopathol Histpathol. 37:123–133. 2015.PubMed/NCBI
20	Lu D, Song H and Shi G: Anti-TNF-α treatment for pelvic pain associated with endometriosis. Cochrane Database Syst Rev. 28:CD0080882013.
21	Agic A, Xu H, Rehbein M, Wolfler MM, Ebert AD and Hornung D: Cognate chemokine receptor 1 messenger ribonucleic acid expression in peripheral blood as a diagnostic test for endometriosis. Fertil Steril. 87:982–984. 2007. View Article : Google Scholar : PubMed/NCBI
22	Xu H, Schultze-Mosgau A, Agic A, Diedrich K, Taylor RN and Hornung D: Regulated upon activation, normal T cell expressed and secreted (RANTES) and monocyte chemotactic protein 1 in follicular fluid accumulate differentially in patients with and without endometriosis undergoing in vitro fertilization. Fertil Steril. 86:1616–1620. 2006. View Article : Google Scholar : PubMed/NCBI
23	Lebovic DI, Chao VA, Martini JF and Taylor RN: IL-1beta induction of RANTES (regulated upon activation, normal T cell expressed and secreted) chemokine gene expression in endometriotic stromal cells depends on a nuclear factor-kappaB site in the proximal promoter. J Clin Endocrinol Metab. 86:4759–4764. 2001. View Article : Google Scholar : PubMed/NCBI
24	Hornung D, Bentzien F, Wallwiener D, Kiesel L and Taylor RN: Chemokine bioactivity of RANTES in endometriotic and normal endometrial stromal cells and peritoneal fluid. Mol Hum Reprod. 7:163–168. 2001. View Article : Google Scholar : PubMed/NCBI